The fund outperformed its benchmark with a 1.66% return for the quarter ending September 30, 2025. Click here for more on ...

The year 2025 has not been a great one for U.S.-Chinese relations. Tit-for-tat tariffs and the scramble over rare earth ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Optimized Gel Formulation Demonstrates Clinical Success in Third Cohort of Patients PRINCETON, N.J., Dec. 17, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ...

Study results support advancing SGX945 in this difficult-to-treat orphan disease Results suggest potential durability of response for maintenance therapy PRINCETON, N.J., Dec. 18, 2025 ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

Follow the steps below to download the CBSE Time Table 2026 PDF for Classes 10 and 12 from the official CBSE website: Visit the official CBSE website: Go to cbse.gov.in. Click on the “Main Website” ...

The review reports that blockchain-enhanced federated learning systems typically achieve slightly lower raw accuracy than ...

This special report segment highlights the ongoing political discourse surrounding the Narendra Modi-led government and ...

This useful study provides a systematic and solid comparison of sex-biased enteroendocrine peptide expression, including AstC and Tk, to show that these peptides contribute to female-biased fat ...

Pfizer Inc. is rated a Hold due to structural challenges despite recent 12% total return and compelling 6.7% dividend yield.

Multimodal Learning, Deep Learning, Financial Statement Analysis, LSTM, FinBERT, Financial Text Mining, Automated Interpretation, Financial Analytics Share and Cite: Wandwi, G. and Mbekomize, C. (2025 ...